Crossmark

Glioblastoma glycolytic signature predicts unfavorable prognosis, immunological heterogeneity, and ENO1 promotes microglia M2 polarization and cancer cell malignancy

Crossref DOI link: https://doi.org/10.1038/s41417-022-00569-9

Published Online: 2022-12-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Liang, Xisong https://orcid.org/0000-0001-6056-1609
Wang, Zeyu

Dai, Ziyu

Zhang, Hao

Zhang, Jian

Luo, Peng https://orcid.org/0000-0002-8215-2045
Liu, Zaoqu https://orcid.org/0000-0002-0452-742X
Liu, Zhixiong

Yang, Kui

Cheng, Quan https://orcid.org/0000-0003-2401-5349
Zhang, Mingyu https://orcid.org/0000-0003-4707-8393
License Information

Text and Data Mining valid from 2022-12-09

Version of Record valid from 2022-12-09
More Information

Article History

Received: 20 February 2022

Revised: 1 November 2022

Accepted: 17 November 2022

First Online: 9 December 2022

Competing interests

: The authors declare no competing interests.

: Ethical approval is not needed because this study does not contain animals and other human subjects.

Document is current

Any future updates will be listed below